Interstitial Keratitis Treatments

Find Interstitial Keratitis Treatments

Generic Name

Acyclovir

Brand Names
Avaclyr, Xerese, Zovirax
FDA approval date: March 29, 1982
Classification: Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor
Form: Ointment, Injection, Cream, Tablet, Suspension, Capsule

What is Avaclyr (Acyclovir)?

AVACLYR is a sterile topical antiviral indicated for the treatment of acute herpetic keratitis in patients with herpes simplex virus. AVACLYR 3%, a herpes simplex virus nucleoside analog DNA polymerase inhibitor, is indicated in the treatment of acute herpetic keratitis in patients with herpes simplex virus.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)

Background: \- KSHV inflammatory cytokine syndrome (KICS) is a newly recognized disease caused by Kaposi sarcoma-associated herpesvirus (KSHV). This virus can cause cancer. People with KICS can have severe symptoms. They include fever, weight loss, and fluid in the legs or abdomen. People with KICS may also be at risk of getting other cancers associated with KSHV. These cancers include Kaposi sarcoma and lymp...

A Phase 1b, Multicenter, Dose Escalation, Evaluation of Safety and Tolerability of ASP7317 for Geographic Atrophy Secondary to Age-related Macular Degeneration

Summary: Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the retina - the light-sensitive part at the back of the eye. There are 2 types of AMD - wet AMD and dry AMD. The advanced stage of dry AMD causes vision loss. This is known as geographic atrophy. AMD makes everyday tasks lik...

Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.

Background: Infections of the central nervous system (CNS) are associated with high morbidity, mortality, and high resource consumption. The BioFire FilmArray is a molecular diagnostic panel capable of identifying 14 pathogens in approximately one hour, including bacteria, viruses, and fungi. However, it is not yet widely available in the Brazilian public health system.

Brand Information

    Avaclyr (ACYCLOVIR)
    1INDICATIONS AND USAGE
    AVACLYR is a sterile topical antiviral indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus.
    2DOSAGE AND ADMINISTRATION
    The recommended dosing regimen is to apply a 1 cm ribbon of ointment in the lower cul-de-sac of the affected eye 5 times per day (approximately every 3 hours while awake) until the corneal ulcer heals and then a 1 cm ribbon 3 times per day for 7 days.
    3DOSAGE FORMS AND STRENGTHS
    AVACLYR is an ophthalmic ointment containing 3% acyclovir.
    4CONTRAINDICATIONS
    AVACLYR is contraindicated for patients who develop sensitivity to acyclovir or valacyclovir.
    5ADVERSE REACTIONS
    The most common adverse reactions (2-10%) reported in patients were eye pain (stinging), punctate keratitis and follicular conjunctivitis. Rare reports of blepharitis and very rare reports of immediate hypersensitivity reactions including angioedema and urticaria have been observed post-marketing in patients taking AVACLYR.
    6DRUG INTERACTIONS
    No clinically significant interactions have been identified resulting from topical administration of other drugs concomitantly with AVACLYR.
    7OVERDOSAGE
    Overdosage of topical application of acyclovir 3% is unlikely because of minimal absorption.
    8DESCRIPTION
    Acyclovir is a synthetic herpes simplex virus nucleoside analog DNA polymerase inhibitor. The drug substance is a white crystalline powder with the molecular formula of C
    The chemical name of acyclovir is 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]6H-purin-6-one, it has the following chemical structure:
    Chemical Structure
    AVACLYR is a sterile ointment for topical administration in eyes. Each gram of ointment contains 30 mg of acyclovir in a white petrolatum base.
    9CLINICAL STUDIES
    In five randomized, double masked studies which enrolled a total of 238 subjects with dendritic herpetic keratitis, acyclovir ophthalmic ointment, 3% was either superior or as effective as idoxuridine ophthalmic ointment 0.5% or 1% in subjects with dendritic ulcers. Clinical resolution (healed ulcers) at Day 7 averaged 83% for acyclovir and 50% for idoxuridine.
    10HOW SUPPLIED/STORAGE AND HANDLING
    AVACLYR is available in a 3.5 g aluminum tube with a white high density polyethylene cap as a clear, colorless, sterile ophthalmic ointment for topical use containing 3% acyclovir active drug. Each tube is packaged in an individual carton.
    3.5 g tube (NDC 48102-028-35)
    Store at 15°C to 25°C (59°F to 77°F).
    11Principal Display Panel - 30 mg Carton Label
    FERA
    NDC 48102-028-35
    Avaclyr
    (Acyclovir
    For
    STERILE
    3.5g Net Wt. Rx only
    Principal Display Panel - 30 mg Carton Label
    12Principal Display Panel - 30 mg Tube Label
    FERA
    NDC 48102-028-35
    Avaclyr
    (Acyclovir
    Each gram contains:
    acyclovir USP 30 mg
    For Topical
    Sterile
    3.5g Net Wt. Rx Only
    Lot:
    Principal Display Panel - 30 mg Tube Label